Search for: "CELGENE" Results 101 - 120 of 183
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Nov 2017, 6:17 am
Company Name Annual Director Retainer Regeneron Pharmaceuticals $2,074,085 Tesla $1,664,928 The Goldman Sachs Group $575,000 Salesforce.com $550,000 Celgene Corporation $524,871 Reynolds American $496,480 Valeant Pharmaceuticals International $475,000 Allergan PLC $450,000 Everest Re Group, Ltd. $447,030 Oracle $429,172 (more…) [read post]
30 May 2018, 2:00 pm by Mike Mireles
  Interestingly, a New York Times article describes Celgene’s response, here. [read post]
15 Nov 2011, 3:58 pm by California Stem Cell Report
Other potential acquirers could include larger pharmaceutical companies like Celgene Corp., Pfizer Inc. and Teva Pharmaceuticals, which have dabbled in stem cells without making major investments. [read post]
18 Nov 2021, 9:19 am by Cinthia Macie
As a condition of Bristol Meyers Squibb’s acquisition of Celgene, the FTC required the drugmaker to divest the drug to Amgen , the FTC said. [read post]
3 Jan 2019, 12:01 pm by Alaric DeArment -- MedCity News
The acquisition brings together two of the largest drugmakers in the country, both of which are major players in biopharma, particularly oncology. [read post]
25 Jan 2007, 7:16 pm
Par Pharma Thalomid: Celgene v. [read post]
3 Jul 2013, 5:48 am by Editors
The Northern District of Texas court held that a few sentences of an engagement letter provided sufficient advance waiver notice of an unforeseen future conflict, and distinguished a 2008 New Jersey decision with similar facts (Celgene v. [read post]
22 May 2018, 12:47 pm by Patrick A. Malone
But their makers need large batches of Big Pharma samples to work with to develop generics  ─ and more than three dozen major firms like Johnson & Johnson’s Actelion Pharmaceuticals, Celgene, Gilead Life Sciences, Novartis, Pfizer, and Valeant have balked at providing requested products. [read post]
27 Aug 2009, 1:30 am
In 2005, hcrenewal.blogspot.com wrote of the drug Terceva:The New York Times recently reported on the high prices paid for drugs to treat cancer, notably the newer "targeted therapies. [read post]
2 Oct 2008, 10:58 am
Later, Celgene developed Revlimid, a substantially more powerful analogue, having fewer side effects. [read post]
19 Jul 2010, 1:23 am by Darrin Mish
He also confirmed that his tax liability is part of the total damages he is seeking in his case against Celgene. [read post]
27 Jan 2021, 2:01 pm by Dennis Crouch
In that decision, the court also did not explain its decision but rather simply cited to another prior case, Celgene Corp. v. [read post]
21 Apr 2023, 7:07 am by Jordan Duenckel
Celgene, the original plaintiff, brought this Hatch-Waxman suit, asserting that Sandoz’s generic product would infringe the ’638 and ’101 patents. [read post]
24 Oct 2015, 11:19 am by Lawrence B. Ebert
Celgene is up since Hayman filed IPR challenges against in April and May. [read post]
31 May 2013, 3:10 pm by David Jensen
In March, it announced a collaboration with Celgene that provided for an upfront payment of $75 million and promised up to $225 million per product in potential option fees and clinical and regulatory milestones. [read post]
10 Feb 2017, 9:46 pm by Mark Summerfield
  The Supreme Court decision was almost immediately cited by an Australian Patent Hearing Officer, who found that a claimed method for commercialising inventions does not constitute patentable subject matter under the Australian ‘manner of manufacture’ test: Invention Pathways Pty Ltd [2010] APO 10.The Invention Pathways decision resulted in an official change to Australian Patent Office practice whereby a claimed invention, to be patent-eligible, would not only need to involve a… [read post]
7 Mar 2014, 3:00 am by David Jensen
Bob HaririHLI photoHariri. the former CEO of Celgene Cellular Therapeutics, is vice chairman and co-founder of the new firm, which is located on a street called “Road to the Cure. [read post]
16 Nov 2011, 4:26 am by Lawrence B. Ebert
“[It] was a business decision,” he said.Californiastemcellreport aggregated a lot of posts on the topic in its piece Possible Buyers for Geron's Stem Cell Business: BioTime, Pfizer, Celgene [read post]